Quarter pole: You survived the Winter That Winter Forgot … and now The March That Wouldn’t Die, as we reach the fifth (!) Friday of the month and the…
By GREGORY ZELLER // A modest state investment will help push a Long Island bioscience pioneer toward the brink of a DNA-manufacturing revolution. Through its Excelsior Jobs Program and chunky…
Short and sweet: Blink and you missed it, dear readers – the first workweek of 2023 is already in the books! Well, almost – just one more workday between…
Put it in the books: It’s Friday in October, friends, and all seems right – Yankees fans are cheering, Mets fans are crushed and you’ve reached the end of…
By GREGORY ZELLER // The latest DNA-based advance by a progressive Long Island biotech goes where other biochemists have gone before – but also blazes a trail for new vaccination…
Are you ready for some football? Welcome to Friday, friends, as we finish the first workweek of September and hunker down for a decidedly autumnal weekend – complete with…
By GREGORY ZELLER // New vaccines produced in part by a progressive Long Island biotech could significantly increase the efficacy of existing cancer treatments. The potential breakthrough – detailed this…
By GREGORY ZELLER // It’s been a big week for one of Long Island’s boldest biotechs. Applied DNA Sciences, a Stony Brook-based leader in polymerase chain reaction-based DNA manufacturing, has…
Is it over? Not quite, dear readers – but the voting is done, there’s a hard stop on those miserable campaign commercials and the endless election signs blockin’ out…
By GREGORY ZELLER // An ambitious Long Island biotech is reporting exciting progress in a two-front battle against the raging novel coronavirus. Stony Brook-based Applied DNA Sciences on Tuesday announced…
By GREGORY ZELLER // With preliminary lab tests looking good, an innovative Long Island biotech is rushing a quintet of potential COVID-19 vaccines overseas. Stony Brook-based Applied DNA Sciences announced…